目的:对穴位贴敷干预慢性阻塞性肺疾病的系统评价和Meta分析进行质量评价。方法:计算机检索Web of Science、the Cochrane Library、EMbase、PubMed、中国生物医学文献数据库(CBM)、中国知网(CNKI)、维普期刊(VIP)和万方数据服务平台(Wanfang)中穴位贴敷干预慢性阻塞性肺疾病的系统评价/Meta分析,检索时限为建库起至2022年4月。两名研究人员按照纳排标准独立筛选文献、提取数据,并运用AMSTAR 2、GRADE进行方法学质量和证据质量评价。结果:最终纳入9篇Meta分析,使用AMSTAR 2行方法学质量评价,发现9篇文献均为极低质量。GRADE证据分级显示,在39个结局指标中,中等质量14个,低质量18个,极低质量7个,无高级别证据。结论:穴位贴敷干预慢性阻塞性肺疾病有低质量循证医学证据支持,但系统评价方法学质量较低,且证据质量等级不高,有待进一步研究考证。
Objective: To evaluate the quality of the systematic review and meta-analysis of acupoint application on chronic obstructive pulmonary disease (COPD). Methods: Web of Science, the Cochrane Library, EMbase, PubMed, CBM, CNKI, VIP and Wanfang Data were searched for systematic reviews/meta-analysis on acupoint application intervention for COPD, and searching time was set from inception of the above databases to April, 2022. Literatures and extracted data were screened by two researchers independently according to the inclusion and exclusion criteria. The AMSTAR 2 and GRADE were used to evaluate the methodological quality and quality of evidence. Results: A total of 9 Meta-analyses were finally included, and AMSTAR 2 evaluation results showed that the 9 papers were all of extremely low quality. The GRADE evidence classification showed that there were 14 indicators of medium quality, 18 indicators of low-level quality, and 7 indicators of extremely low-level quality among 39 outcome indicators. There was no high-level evidence were found. Conclusion: The intervention of acupoint application on chronic obstructive pulmonary disease is supported by low-quality evidence-based medicine. However, the methodological quality of systematic reviews on COPD is low, and the level of evidence quality is not high, which needs further studies to confirm this conclusion.
[1] GOLD Committees. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2021 report[EB/OL]. [2021-11-05]. https://goldcopd.org/2021-gold-reports.
[2] Kendzerska T, Povitz M, Gershon AS. The epidemiology of obstructive sleep apnea and asthma or obstructive pulmonary disease overlap syndromes in Ontario, Canada: a population-based cohort study[J]. Sleep, 2017(suppl_1): A177-A178.
[3] 梁仕勤, 刘红宇, 叶焰, 等. 柴金饮治疗痰浊阻肺型慢性阻塞性肺疾病急性加重期31例[J]. 安徽中医药大学学报, 2021, 40(3): 12-16.
[4] 张广清, 林美珍, 邓丽丽, 等. 广东省中医护理技术临床应用现状调查分析[J]. 中国护理管理, 2013, 13(12): 80-83.
[5] Herrera-Perez D, Haslam A, Crain T, et al. A comprehensive review of randomized clinical trials in three medical journals reveals 396 medical reversals[J]. Elife, 2019, 8: e45183.
[6] Pieper D, Büchter RB, Li L, et al. Systematic review found AMSTAR, but not R(evised)-AMSTAR, to have good measurement properties[J]. J Clin Epidemiol, 2015, 68(5): 574-583.
[7] 曾宪涛, 冷卫东, 李胜, 等. 如何正确理解及使用GRADE系统[J]. 中国循证医学杂志, 2011, 11(9): 985-990.
[8] Shea BJ, Reeves BC, Wells G. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both[J]. BMJ, 2017, (8122): 358.
[9] 李宁. 中医特色疗法治疗稳定期慢性阻塞性肺疾病临床疗效的Meta分析[D]. 郑州:河南中医药大学, 2017.
[10] 程军平, 牛广豪, 陈竞纬, 等. 冬病夏治穴位敷贴防治慢性阻塞性肺疾病系统评价[J]. 中医药临床杂志, 2019, 31(12): 2270-2276.
[11] 林飞雪, 郑景辉, 钟美容, 等. 三伏贴防治慢性阻塞性肺疾病的Meta分析[J]. 广西中医药, 2016, 39(4): 76-80.
[12] 吴迪, 杨程, 童佳兵, 等. 穴位敷贴防治慢性阻塞性肺疾病的Meta分析[J]. 世界科学技术-中医药现代化, 2019, 21(11): 2491-2498.
[13] 于健健, 王珺, 蔡成森. 穴位贴敷对稳定期COPD患者肺康复影响的Meta分析[J]. 中医临床研究, 2018, 10(25): 1-5.
[14] 王倩, 赵仓焕. 穴位敷贴治疗COPD缓解期随机对照临床研究文献的Meta分析[J]. 现代中医药, 2014(3): 44-48.
[15] 胡海宇, 孙敏燕, 朱正阳, 等. 穴位贴敷干预慢性阻塞性肺疾病稳定期系统评价和Meta分析[J]. 上海针灸杂志, 2019, 38(8): 932-940.
[16] Li FS, Gao Z, Jing J, et al. Effect of point application on chronic obstructive pulmonary disease in stationary phase and effects on pulmonary function: a systematic evaluation of randomized controlled trials[J]. J Tradit Chin Med, 2012, 32(4): 502-514.
[17] Wu JJ, Zhang YX, Xu HR, et al. Effect of acupoint application on T lymphocyte subsets in patients with chronic obstructive pulmonary disease: a meta-analysis[J]. Medicine (Baltimore), 2020, 99(16): e19537.
[18] 王迪, 李迅, 胡瑞学, 等. 国内中文期刊中医药系统综述和Meta分析发表偏倚情况及改进措施[J]. 中医杂志, 2019, 60(13): 1102-1107.
[19] Azarisman MS, Fauzi MA, Faizal MPA, et al. The SAFE (SGRQ score, air-flow limitation and exercise tolerance) Index: a new composite score for the stratification of severity in chronic obstructive pulmonary disease[J]. Postgrad Med J, 2007, 83(981): 492.
[20] 陶欢, 杨乐天, 平安, 等. 随机或非随机防治性研究系统评价的质量评价工具AMSTAR 2解读[J]. 中国循证医学杂志, 2018, 18(1): 101-108.
[21] 魏成功, 符子艺, 陈健英. “冬病夏治”治疗脾肾阳虚型COPD患者36例疗效观察[J]. 亚太传统医药, 2010, 6(6): 55-57.
[22] 冯伟伟, 苏婕, 步伟全, 等. “冬病夏治”中药穴位敷贴联合西医治疗儿童哮喘疗效观察[J]. 现代中西医结合杂志, 2020, 29(32): 3608-3611.
[23] 李国勤, 王蕾, 林英翔, 等. 冬病夏治消喘膏穴位贴敷疗法治疗稳定期慢性阻塞性肺病的随机对照研究[J]. 中国中西医结合杂志, 2011, 31(9): 1187-1190.
[24] 杨洁, 杨彦伟, 张波, 等. 双息咳喘膏贴敷对肺肾两虚型COPD稳定期患者肺功能的影响[J]. 中国中医药科技, 2017, 24(4): 476-477.
[25] 张学梅, 刘凡亮, 梁文波, 等. 白芥子提取物的镇咳、祛痰及平喘作用研究[J]. 中草药, 2003, (7): 62-64.
